UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Common Stock	Additional Paid-in Capital	Comprehensive Income	Retained Earnings	Total
Equity Balance, value at Dec. 31, 2017	$ 37	$ 809	$ (8,341)	$ 85,618	$ 78,123
Equity Balance, shares at Dec. 31, 2017	3,721
Common stock issued upon exercise of employee stock options	$ 0	372	0	0	372
Common stock issued upon exercise of employee stock options, shares	9
Common stock received and retired upon exercise of stock options	$ 0	(225)	0	0	(225)
Common stock received and retired upon exercise of stock options, shares	(2)
Stock option compensation expense	$ 0	30	0	0	30
Foreign currency translation adjustment	0	0	1,301	0	1,301
Common stock dividends	0	0	0	(1,006)	(1,006)
Net income	0	0	0	4,092	4,092
Equity Balance, value at Mar. 31, 2018	$ 37	986	(7,040)	88,704	82,687
Equity Balance, shares at Mar. 31, 2018	3,728
Equity Balance, value at Dec. 31, 2018	$ 37	121	(11,290)	100,124	88,992
Equity Balance, shares at Dec. 31, 2018	3,720
Common stock issued upon exercise of employee stock options	$ 0	97	0	0	97
Common stock issued upon exercise of employee stock options, shares	3
Stock option compensation expense	$ 0	28	0	0	28
Foreign currency translation adjustment	0	0	948	0	948
Common stock dividends	0	0	0	(1,028)	(1,028)
Net income	0	0	0	3,139	3,139
Equity Balance, value at Mar. 31, 2019	$ 37	$ 246	$ (10,343)	$ 102,235	$ 92,176
Equity Balance, shares at Mar. 31, 2019	3,723